Prophylactic pacemaker use to allow h-blocker therapy in patients with chronic heart failure with bradycardia
نویسندگان
چکیده
Background Although the benefits of h-blocker therapy for patients with congestive heart failure (CHF) are independent of pretreatment heart rate, patients with chronic systolic heart failure and low resting heart rates are often excluded from h-blocker therapy. We investigated the effectiveness and cost-effectiveness of prophylactic pacemaker insertion to facilitate h-blocker use in these patients.
منابع مشابه
Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia
Health technology The study compared two treatment strategies for patients with chronic heart failure (CHF). The strategies compared were the conventional strategy and the pacemaker-carvedilol strategy. In the conventional strategy, patients were treated with angiotensin-converting enzyme inhibitors, diuretics and digoxin. In the pacemaker-carvedilol strategy, patients received conventional tre...
متن کاملProphylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia.
BACKGROUND Although the benefits of beta-blocker therapy for patients with congestive heart failure (CHF) are independent of pretreatment heart rate, patients with chronic systolic heart failure and low resting heart rates are often excluded from beta-blocker therapy. We investigated the effectiveness and cost-effectiveness of prophylactic pacemaker insertion to facilitate beta-blocker use in t...
متن کاملPhosphodiesterase 2 as a Therapeutic Target for Heart Failure
Heart failure (HF) is a chronic progressive cardiac disease with high morbidity and mortality. A key pathophysiological feature of HF is chronic overexcitation of the sympathetic nervous system and release of catecholamines. The subsequent activation of cardiac β-adrenoceptors (β-ARs) results in molecular and structural changes that lead to cardiac hypertrophy, myocardial fibrosis, or electrome...
متن کاملPhosphodiesterase 2 as a Therapeutic Target for Heart Failure: Is Upregulation an Option?
Heart failure (HF) is a chronic progressive cardiac disease with high morbidity and mortality. A key pathophysiological feature of HF is chronic overexcitation of the sympathetic nervous system and release of catecholamines. The subsequent activation of cardiac β-adrenoceptors (β-ARs) results in molecular and structural changes that lead to cardiac hypertrophy, myocardial fibrosis, or electrome...
متن کاملCombination therapy with carvedilol and amiodarone in patients with severe heart failure.
BACKGROUND Carvedilol and at least in some studies, amiodarone have been shown to improve symptoms and prognosis of patients with heart failure. There are no reports on the outcome of combined treatment with both drugs on top of angiotensin-converting enzyme inhibitors (ACEI), diuretics and digitalis. METHODS AND RESULTS In 109 patients with severe heart failure submitted for heart transplant...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2006